Article
Interleukin-36 promotes systemic Type-I IFN responses in severe psoriasis.
2018-12-14
Abstract excerpt
Psoriasis is an immune-mediated skin disorder associated with severe systemic co-morbidities. Both chronic and acute forms of the disease are characterised by abnormal interleukin (IL)-36 signalling. While the mechanisms whereby IL-36 promotes cutaneous inflammation are well established, its systemic effects have not been investigated. To address this issue, we initially measured leukocyte gene expression in gener...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0576f334-b380-56d2-b12c-9b3e54e5a726
- DOI
- 10.1101/496851
